David Araujo-Vilar, re-elected president of the European Lipodystrophy Consortium
USC CiMUS researcher David Araújo-Vilar has just been re-elected president, for the second consecutive term, of the European Consortium of Lipodystrophies (ECLip). This is a network of excellence in clinical and basic research in rare lipodystrophies that brings together 57 groups from 27 countries around the world.
His re-election took place in the framework of the General Assembly of the Consortium, held last week in Pisa, which addressed the renewal of its Board of Directors, as well as the celebration of its 9th symposium.
David Araújo-Vilar graduated in Medicine and Surgery from the University of Santiago de Compostela in 1985, where he obtained his doctorate five years later. Subsequently, he undertook postdoctoral studies at the University of Oxford, at the Radcliffe Infirmary (1989-1991). From 1992 to 1996 he began his teaching career in the Department of Medicine of the USC and since 1998 he has been a full professor of Medicine, with a post linked to the CHUS since 2006 as a specialist in Endocrinology and Nutrition.
In 2003 Araújo-Vilar created together with Professor Lado-Abeal the Unit of Thyroid and Metabolic Diseases (UETeM), which he directs at the CiMUS with the intention of deepening research into rare lipodystrophies and other syndromes of severe insulin resistance, both in their clinical aspects and in their molecular basis.
He is the author of more than 50 scientific papers, most of them in the field of lipodystrophies. He is also the founding president of the Spanish Association of Lipodystrophies and a member of the Expert Committee of the Spanish Federation of Rare Diseases. In 2014 he was one of the founders of the European Consortium of Lipodystrophies (ECLip) in Bologna. In the associative field, focused on supporting the needs of patients, he is a member of the Board of Directors of the Asociación de Familiares y Afectados de Lipodistrofias (AELIP).